Stay updated on Pembrolizumab in Advanced Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Sarcomas Clinical Trial page
- Check4 days agoChange DetectedLocations were added and state-specific location sections were reorganized; the page now presents trial sites by state (CA, DC, FL, MI, MN, MO, NY, NC, OR, PA) under Locations. The HHS Vulnerability Disclosure link was removed and the revision label updated from v3.3.2 to v3.3.3.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedPublications section now states that PubMed-derived publications are automatically filled and may not be about the study. The page revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoved a government funding status notice that previously informed users about potential delays and operating status; the study page content and eligibility information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check55 days agoChange DetectedNo substantive changes to the study details were detected; arms, eligibility criteria, outcomes, and locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange DetectedNew operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.SummaryDifference3%

- Check90 days agoChange DetectedUpdated taxonomy: broader bone-related disease categories added; several specific terms removed; software revision bumped to v3.1.0.SummaryDifference0.7%

Stay in the know with updates to Pembrolizumab in Advanced Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.